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utoimmune diseases are generally more com-
mon in women. One of these is multiple scle-
rosis (MS), a disease that has a female:male ratio of
about 2-3:1. The etiology of MS is not known, but
there is considerable circumstantial evidence that
an immune response to central nervous system
(CNS) myelin proteins is important in pathogen-
esis.
Multiple sclerosis is a multifocal inflammatory
disease affecting only the CNS. The target of the
inflammatory response is CNS myelin and the my-
elin-producing cells, oligodendrocytes. The myelin
is destroyed in patches, resulting in the formation
of astrocytic scars called plaques. Areas of inflam-
mation are characterized by accumulations of large
numbers of 1ymphocytes (predominantly T cells)
and macrophages. Increased concentrations of cy-
tokines and chemokines also are present in regions
of inflammation, as are antibodies to myelin pro-
teins. 1-s
The course of MS is highly variable, ranging in
severity from an incidental finding at autopsy to
severe disability and death within months to years
of onset. The variables responsible for these dif-
ferences in clinical course are not known, but at
least two events have been associated with changes
in disease activity. These are infections, especially
viral infections, and the postpartum period.
While there are several possible mechanisms to
explain the association between infections and at-
tacks or relapses of MS, we proposed that immune
responses to an infectious agent’s heat shock pro-
tein (hsp) cross-reacted with endogenous hsp pre-
sent at sites ofCNS inflammation that are the hall-
mark of the disease process in MS. Recruitment of
anti-hsp responsive 1ymphocytes to such regions,
with resulting release of toxic cytokines, could be a
significant factor in either amplifying or perpetuat-
ing the MS disease process. We initiated a series of
studies to support this hypothesis.
STRESS PROTEINS AS TARGETS OF
IMMUNE RESPONSES
There are several characteristics of hsps that in-
crease their potential to act as antigens in the de-
velopment of autoimmune diseases.6 First, hsps are
phylogenetically conserved. Thus, there is greater
than 50% sequence homology between certain pro-
karyotic hsps and that of mammalian cells.6-9 Sec-
ond, hsps are the immunodominant antigens for
many infectious agents, including bacteria, myco-
bacteria, and parasites.1,1 Third, hsps are ex-
pressed at sites of acute and chronic inflamma-
tion. le,13 Thus, exposure to an infectious agent in a
genetically susceptible host at the appropriate time
during the host’s development may result in an
immune response to the infecting agent’s hsp that
either cross-reacts with normal host hsp or cross-
reacts with organ-specific proteins, resulting in an
autoimmune disease.
HEAT SHOCK PROTEINS AND
MULTIPLE SCLEROSIS
The evidence that MS is an autoimmune disease,
or for that matter, an immunologically mediated
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disease, is circumstantial. Numerous attempts to
find immune responses to unique antigens in.per-
sons with MS or to find immune responses to my-
elin and other antigens not present in normal indi-
viduals have not succeeded to date. Persons with
MS do have increased immune responses to a va-
riety of myelin antigens, including myelin basic
protein (MBP), proteolipid protein (PLP), and my-
elin/oligodendrocyte glycoprotein (MOG),14-2 and
increased numbers of activated T cells responsive
to these antigens. 14,21 In addition, many of the my-
elin antigens recognized by MS (and normal) T
cells are potent autoantigens capable of inducing
experimental autoimmune encephalomyelitis
(EAE), an animal model for MS.22 The presence of
increased numbers of myelin reactive cells in per-
sons with MS clearly indicates sensitization to such
proteins. However, it is not clear whether the
heightened immune responses to these antigens
are primary or secondary to the disease process, nor
is it known what role these responses play either in
disease initiation or perpetuation.
As noted above, there is a well documented as-
sociation between MS disease activity and anteced-
ent infections.23,24 The study by Sibley and asso-
ciates showed a clear association between infec-
tions, usually viral, and attacks or worsening of
disease. While preexistent symptoms of MS will
worsen during the acute phase of an infection, es-
pecially if there is an associated fever, true disease
exacerbations occur days to weeks after recovery.
Several mechanisms could explain the associa-
tion between infection and the worsening of an
organ-restricted, inflammatory, possibly autoim-
mune disease:
1. Infections result in increased concentrations of
circulating cytokines. Some of these, such as tu-
mor necrosis factor (TNF) or interferon (INF)-
gamma, in addition to having direct effects on
oligodendrocytes, could alter the blood-brain
barrier, allowing easier entry of myelin-specific
immunocompetent cells and/or antibodies. Cy-
tokines could also nonspecifically activate anti-
myelin T cells resident within the CNS of MS
patients.
2. Infections result in immune responses to the
infectious organism’s hsps. These immune re-
sponses could cross-react with phylogenetically
conserved hsp expressed by oligodendrocytes in
areas of inflammation,zs
3. Immune responses to an infectious agent’s hsp
could cross-react with myelin antigens, resulting
in myelin destruction.
4. A combination of the above effects may be im-
portant.
A variety of approaches have been used to de-
termine whether hsps, or immune responses to
hsps, are involved in the pathogenesis of MS.
These include studies of the following areas:
a. The expression of hsp in the brains of persons
with MS
b. Immune responses to hsp in MS patients
c. Cross-reactivity between hsp and CNS myelin.
In addition, several laboratories studied the
distribution of gamma/delta T cells in MS brains
and spinal fluids,z6-z9 While most T cells that re-
spond to hsp express the alpha/beta receptor com-
plex, a high proportion (>-50%) ofT cells express-
ing gamma/delta receptors respond to hsp. Results
of these studies revealed that there were increased
numbers of gamma/delta T cells around areas of
demyelination as well as in the spinal fluids during
acute exacerbations and that greater numbers of
gamma/delta cells were found in the cerebrospinal
fluid (CSF) of individuals with shorter duration of
disease,e7 These data provide circumstantial sup-
port for the hypothesis that immune responses to
hsps may play a role in MS pathogenesis.
Expression of Heat Shock Proteins in Multiple
Sclerosis Central Nervous System
Several laboratories studied expression of hsps in
areas of MS demyelination. Selmaj and his associ-
ateszs,3 demonstrated expression of Hsp65 in im-
mature oligodendrocytes at the edges of MS
plaques. There also was constitutive expression of
Hsp72 in MS and non-MS brain, especially in as-
trocytes. Wucherpfennig et al.z6 demonstrated ex-
pression of Hsp60 in foamy macrophages at the
edges of acute plaques and expression of Hsp90 in
reactive astrocytes. In our studies, we utilized a
panel of 20 monoclonal and polyvalent antibodies
to human and mycobacterial hsp to immunocyto-
chemically stain fixed, frozen sections of normal
and MS brains.1 Patterns of staining varied with
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different antibodies. Some antibodies stained cell
bodies of neurons and astrocytes. Others stained
neurofilaments. A small number of antibodies (dis-
cussed below) stained normal myelin. In sections
of spinal cord, staining of both central and periph-
eral myelin was observed. We could not detect in-
creased staining at the edges of either acute or
chronic plaques. Indeed, demyelinated areas did
not stain at all. Thus, there are epitopes on normal
myelin that are recognized by monoclonal antibod-
ies to mycobacterial hsp.
Using a different approach, a number of labora-
tories studied the expression of hsp by glial cells in
vitro. Again, results varied with the techniques and
antibodies used for the assays. Selmaj et al.,3
Freedman et al.,3e and Satoh et al.3 identified oli-
godendrocytes as cells expressing hsp. Selmaj et al.
detected constitutive Hsp65 expression in oligo-
dendrocytes but not astrocytes, yet noted some
HspT0/72 expression in astrocytes. Satoh et al. de-
tected constitutive expression of Hsp60 in cultured
murine oligodendrocytes and "marginally detect-
able" levels in most astrocytes. Expression of
Hsp60 was increased in oligodendrocytes following
heat stress. Freedman et al. detected constitutive
expression of Hsp60 and Hsp70/72 expression in
oligodendrocytes with increased expression of
HspT0/72 following heat stress. No astrocytes ex-
pressed HspT0/72, and only a small percentage of
astrocytes expressed Hsp60. In contrast, Marini
and coworkers,4 using tissue cultures of rat astro-
cytes and neurons, demonstrated heat inducible
expression of Hsp70 predominantly in astrocytes,
but oligodendrocytes may have been absent from
these cultures. Using purified cultures of rat astro-
cytes, Dwyer et al.s demonstrated that such cells
synthesized hsps of 30-34, 68, 70, 89, and 97 kD
and that exposure to heat readily induced expres-
sion of Hsp65.
Since MS is an inflammatory disease, concentra-
tions of cytokines are increased in MS brain.4,s
D’Souza et al.zs studied the effects of cytokines on
the expression of hsp in mixed cultures of human
glial cells.31,3z A mixture of cytokines induced ex-
pression of Hsp72, predominantly in oligodendro-
cytcs. The specific cytokines involved in this in-
duction were interleukin (IL)-I, INF-gamma, and
TNF-alpha. In unpublished studies, we prepared
cultures of purified murine astrocytes and exposed
them to heat shock (43C) with or without expo-
sure to a mixture of cytokines. Cytokines alone
induced small amounts of Hsp70/72. However the
combination of heat shock and cytokine exposure
augmented expression of Hsp70/72 two- to 11-fold.
The cytokines responsible for this phenomenon
were INF-gamma and TNF-alpha.
The above data show that results can vary
widely, depending on the specificities of the anti-
bodies used and the particular methods used for
study. Nevertheless, there is good evidence that
some antibodies to hsp bind to normal myelin
while others bind to oligodendrocytes or astrocytes.
In addition, the inflammatory milieu within MS
brains increases the expression of hsp within glia,
increasing the possibility that immune responses to
infectious agents’ hsp could cross-react with their
human hsp homologues or cross-reactive myelin
epitopes.
Immune Responses to Heat Shock Proteins in
Multiple Sclerosis Patients and Controls
Work in this area can be divided into studies in-
volving cellular immune responses and those in-
volving humoral responses.
Two groups described cellular immune re-
sponses to hsps in persons with MS and other neu-
rologic disorders: Salvetti et al.36 and our labora-
tory.37 Salvetti et al. studied peripheral blood T-
cell proliferative responses to recombinant Hsp65
and Hsp70 from Mycobacterium bovis in 31 persons
with MS, 19 individuals with other neurologic dis-
orders, and 19 normal controls. Proliferative re-
sponses to Hsp70 were significantly more frequent
in persons with MS compared to those with other
ncurologic disorders and healthy controls. Re-
sponses to Hsp65 were equivalent in the three
groups. Lines of T cells were established from 10
MS patients and 12 healthy controls, using purified
protein derivative as antigen. Again, Hsp70 reac-
tive lines were significantly more common in MS
patients than in healthy controls. Interestingly, cy-
tofluorometric analyses of purified protein deriva-
tive responsive lines revealed that only a minority
of responding cells expressed gamma/delta T-cell
receptors. Our laboratory studied T-cell prolifera-
tive responses to elIycobacterium tuberculosis, tetanus
toxoid, and recombinant Hsp65 from Mycobacterium
leprae. T cells were concurrently collected from the
peripheral bloods and spinal fluids of 20 persons
with MS and nine persons with inflammatory neu-
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rologic diseases other than MS. Cells were cultured
in vitro and stimulated with the above antigens.
Significantly increased spinal fluid lymphocyte
proliferative responses to mycobacterial sonicate,
relative to responses from paired peripheral blood
lymphocytes, were present in 14 of the 20 speci-
mens from patients with MS, compared to two of
nine specimens from patients with other neurologi-
cal diseases (P < 0.025). Spinal fluid lymphocytes
also responded to tetanus toxoid, but differences
between blood and spinal fluid were not statisti-
cally significant. Lymphocytes from one patient
with MS responded only to recombinant Hsp65.
When MS patients were classified according to du-
ration of disease, nine of 10 with duration less than
2 years had spinal fluid T cells responding to M.
tuberculosis, compared with five out of 10 with dis-
ease longer than 2 years (P < 0.012). These data
supplement the observations of Shimonkevitz et
al.z7 that described increased numbers of activated
gamma/delta cells predominantly in spinal fluids
from persons with recent onset MS.
Studies of humoral immune responses to hsp in
MS are mainly the work of our laboratory38,39 and
that of Freedman and his associates.4 We used
immunoblots to detect antibodies to native and re-
combinant mycobacterial and bacterial hsp in
paired spinal fluids and sera from persons with MS
and other neurologic diseases. Antibodies to many
hsps, including those of the 60kD and 70kD fami-
lies, were present in CSF and sera from all patient
groups. Patterns of antibodies varied between CSF
and sera, and between patients, but no disease-
distinctive patterns were seen. When anti-hsp an-
tibodies were analyzed for isotypes, patients with
MS had higher concentrations of anti-hsp immuno-
globulin (Ig) A antibodies than did patients with
other neurologic diseases. This suggested an in situ
synthesis of such antibodies within the CNS in
persons with MS. Prabhakar et al.4 studied anti-
body concentrations to recombinant Hsp 60 using
enzyme-linked immunosorbent assay (ELISA). Ti-
ters of antibodies in MS spinal fluids were signifi-
cantly higher than those seen in persons with other
neurologic diseases, and the higher titers correlated
with the presence of oligoclonal bands in MS CSF
but not CSF of those with other neurologic dis-
eases. In another recent study, Gao et al.41 demon-
strated the presence of antibodies to mycobacterial
Hsp65 and human Hsp60 in spinal fluids of persons
with MS as well as those with other neurologic
illnesses. In this study, immune responses to hsp
were not disease specific.
The presence of immune responses to hsp in
spinal fluids of persons with a variety of chronic
inflammatory CNS diseases is not unexpected,
since exposure to cytokines and inflammatory cells
increases expression of these proteins and could
result in an accumulation of anti-hsp T cells and
antibodies in this anatomic compartment. How-
ever, since all of the above studies used large pro-
tein molecules as antigens, immune responses to
particular hsp epitopes could not be detected, nor
were differences in cytokine secretion studied.
Patterns of immune responses to particular hsp
peptides vary among individuals, depending on
differences in their major histocompatibility com-
plex (MHC) genes and their different illnesses.4z
Such differences in patterns of immune response,
especially those related to individual MHC geno-
types, may be important in determining suscepti-




While there is no completely comparable animal
model for MS, EAE, an autoimmune CNS disease
induced by immunization with myelin proteins or
peptides, has served as a useful tool in studying
potential disease processes in human CNS autoim-
mune diseases. Several approaches, similar to those
used in studies with patients with MS, have
yielded persuasive data for a role of immune re-
sponses to hsp in animals with EAE.
Responsiveness to Heat Shock Proteins in the
Central Nervous System of Rats With
Experimental Autoimmune Encephalomyelitis
Mor et al.43 were among the first to present data in
support of the hypothesis that immune responses
to hsps play a role in autoimmune demyelination.
These investigators prepared T cells from the spi-
nal cords, blood, spleen, and lymph nodes of rats
during the acute phase of EAE or during recovery
from EAE. Using limiting dilution analyses, they
determined the frequency of T-cell responses to
the myelin protein, MBP, and to recombinant
Hsp65 and HspT0. As expected, responses to MBP
were enriched in the spinal cords of rats during and
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after acute EAE. However, there was also enrich-
ment of T cells responsive to Hsp65. T-cell lines
established from spinal cord lymphocytes re-
sponded to MBP, Hsp65, and Hsp70. When EAE
was induced with an anti-MBP responsive T-cell
line, similar patterns of enrichment for MBP and
Hsp65 reactive T cells were noted, indicating that
responses to hsp occurred in the absence of expo-
sure to adjuvant mycobacteria.
Modulation of Experimental Autoimmune
Encephalomyelitis by Immunization With Heat
Shock Proteins
While studies with MS patient materials suggested
that immune responses to hsp may play a role in
pathogenesis, the best evidence for such a phe-
nomenon comes from studies of EAE.
As noted above, we found that certain anti-hsp
antibodies stain normal myelin. We extended these
observations by performing immunoblots with nor-
mal human myelin as antigen.
31 A panel of 20 anti-
stress protein antibodies was assayed for their
ability to bind to normal human myelin proteins
separated on SDS-PAGE. Three monoclonal anti-
bodies, specific for either mycobacterial or human
hsp, stained bands of normal myelin proteins. One
routine monoclonal to M. leprae Hsp65, IIH9,
stained a 44-46 kD doublet. This doublet was the
same size as the myelin protein 2’, 3’, cyclic 3’
nucleotide phosphodiesterase (CNP). To study
this observation further, purified CNP was used in
immunoblots. IIH9 bound to CNP in a pattern
identical to that seen with whole myelin. A nona-
peptide region of sequence homology was identi-
fied between the epitope of Hsp65 recognized by
IIH9 and CNP. This peptide (hsp-CNP peptide)
was synthesized and used in immunoblots. IIH9
strongly bound to this peptide, proving that this
region of sequence homology was responsible for
the observed cross-reactivity.
To determine whether immune responses to
this peptide had biologic consequences, we immu-
nized rats with hsp-CNP peptide, using either
complete or incomplete Freund’s adjuvant, the
only difference between the two adjuvants being
the presence of heat-killed M. tuberculosis in the
complete Freund’s adjuvant (CFA). No clinical
disease or histologic changes in the CNS were ob-
served. Four weeks later, animals were challenged
with guinea pig spinal cord in CFA. Those animals
that originally received peptide in CFA developed
accelerated and enhanced EAE. Those animals
previously immunized with peptide in incomplete
Freund’s adjuvant (IFA) either remained healthy
(40%) or developed very mild EAE. Differences
between the two groups were statistically signifi-
cant. Thus, an immune response to a hsp peptide
having sequence homology with a myelin protein
modulated the course of EAE.
In an attempt to determine the mechanisms in-
volved in the protection offered by peptide immu-
nization, we measured spleen-cell proliferative re-
sponses of rats immunized with hsp-CNP peptide
upon stimulation with either recombinant, myco-
bacterial Hsp65, hsp-CNP peptide, or no antigen.
Cells were collected at two time points, 12 days
and 31 days after peptide immunization. As ex-
pected, strong proliferative responses were seen at
both time points with cells from animals given pep-
tide in CFA, that is, adjuvant containing mycobac-
teria. In contrast, day-12 spleen cells from rats
given hsp-CNP peptide in IFA did not respond to
Hsp65. This too was expected, since IFA contains
no mycobacteria. However, by day 31 there was a
dramatic change. Spleen cells from rats given pep-
tide in IFA proliferated to Hsp65 stimulation as
strongly as cells from rats given peptide in CFA.
No proliferative responses were seen in spleen
cells from any group when stimulated by hsp-CNP
peptide alone. This latter observation is not unex-
pected since hsp-CNP peptide is a B-cell determi-
nant. We interpret these observations to indicate
that epitope spreading may have occurred follow-
ing immunization with hsp-CNP peptide in IFA.
In other words, even though there were no prolif-
erative response to peptide alone, sufficient T-cell
stimulation was induced to allow diversification of
the response to other epitopes of Hsp65. By 31
days after immunization, numbers of these Hsp65
responsive cells could be detected in our prolifera-
tive assays. The phenomenon of epitope spreading
or diversification of immune responses initiated by
restricted peptide epitopes is an important one that
has significant implications in terms of determining
patterns ofimmune response in any chronic inflam-
matory process, including MS.44,45
We next measured antibodies to Hsp65 and hsp-
CNP peptide in sera from rats immunized 12 and
31 days previously with hsp-CNP peptide in either
CFA or IFA. Antibodies to peptide were present in
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all animal groups. Only one of three rats immu-
nized with peptide in CFA had antibodies to
Hsp65 at 12 or 31 days after immunization. In con-
trast, antibodies to Hsp65 were seen in rats given
peptide in IFA, both 12 days previously (one of
three rats) and 31 days previously (four of four rats).
These results support our hypothesis that, as a re-
sult of immunization with hsp-CNP peptide, epit-
ope spreading occurred such that antibodies to
other determinants of Hsp65 were evoked.
Immune responses can be categorized by the
patterns of cytokines secreted by activated T cells.
Thl responses are those in which T cells secrete
IL-2 and INF-gamma. Th2 responses are those in
which T cells secrete IL-4 and IL-5.4e’46 Thl re-
sponses have been implicated in the pathogenesis
of cell mediated diseases such as MS and EAE.47
We wished to determine the patterns of immune
responses to hsp-CNP peptide in terms of Thl
versus Th2. To do this we determined the isotypes
of the IgG anti-peptide antibodies. Immunoglobu-
lin G2a antibodies require secretion of INF-
gamma. Thus, their presence indicates a Thl pat-
tern of response.
4s Immunoglobulin G1 antibodies
arise in the presence of IL-4 and are an indicator of
a Th2 pattern of T-cell response.48 Anti-peptidc
antibodies from peptide-CFA immunized rats were
a mixture of IgG1 and IgG2a isotypes on day 12
after immunization. By day 31, anti-peptide anti-
bodies were almost exclusively IgG2a, indicating
the presence of a strong Thl response. In contrast,
anti-peptide antibodies in the IFA immunized
group were mainly IgG1 at both time points,
though some IgG2a isotypes were detected on day
31. Thus, protection against EAE was associated
with a Th2 pattern of response. These data are in
agreement with other observations showing that
Thl responses are responsible for the development
of EAE,47’49’5 and that Th2 cytokines, such as
transforming growth factor-beta, protect against
EAE.sl
Lewis rats are susceptible to acute EAE but
rarely go on to have relapses. To study a model of
EAE more closely resembling MS, we induced
EAE in the SJL mouse by immunization with an
cncephalitogcnic peptide of proteolipid protein,
PLP139-151, emulsified in CFA. This results in a
chronic relapsing form of EAE that has many simi-
larities to MS. Following immunization with pep-
tide, animals develop an acute illness from which
almost all recover completely over a period of 10-
14 days. One to three weeks after recovery, mice
begin to have spontaneous relapses of disease. Re-
covery from these attacks is often incomplete, and
some animals develop chronic progressive disabil-
ity. To study the role of hsp in this model mice
were injected intravenously with Hsp60 coupled to
syngeneic spleen cells. Controls received either bo-
vine serum albumin (BSA) or PLP139-151. One
week later, animals were immunized with PLP139-
151 in CFA to induce EAE. All animals became ill
with EAE, though as expected, fewer mice receiv-
ing intravenous PLP139-151 developed EAE, and
those that did had very mild disease. Mice were
then carefully monitored over the ensuing 3
months. Mice given intravenous BSA recovered
from their acute illness and went on to have mild-
to-moderate relapses with good recovery between
attacks. The few mice that became ill in the intra-
venous-PLP139-151 group recovered completely
and never experienced relapses. Mice pretreated
with Hsp60 had disease as severe as BSA-
pretreated mice, indicating that their acute EAE
was not modified by exposure to Hsp60. However,
over the ensuing 3 months, Hsp60-treated animals
experienced a significant increase in the severity
and frequency of their relapses, as well as sustain-
ing incomplete recovery between attacks. While
the reasons for this effect remain to be elucidated,
it is clear in this model that immune responses to
hsps play an important role not in the acute phase
of EAE induced by peptide, but in the relapses
that occur subsequent to recovery. An understand-
ing of the mechanisms involved in this phenom-
enon may shed light on the causes of relapses in
persons with MS.
Environmental Infections Influence the Course
of Experimental Autoimmune Encephalomyelitis
Since infections in humans are associated with an
increased frequency ofMS relapses we studied the
role of infections in mice immunized with PLP139-
151 to induce relapsing EAE. We studied two
groups of mice. One group was housed in a spe-
cific-pathogen-free (SPF) facility where frequen-
cies of infections were greatly reduced and only
normal commensal bacteria were present in the
animals. The other group of mice was housed in a
conventional facility where animals are routinely
exposed to a large number of viral, bacterial, and
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parasitic infectious agents. We wished to alter the
normal pattern of immune responses to hsp in
these animals, skewing them toward either a Thl
(presumably disease exacerbating) or Th2 (pre-
sumably disease ameliorating) bias. To do this, ani-
mals in both groups were injected intrapcritoneally
with either CFA or IFA. Complete Freund’s adju-
vant induces a Thl pattern of immune response to
Hsp60, whereas IFA induces a Th2 pattern of re-
sponse to this protein,sz Our published resultss3
showed the following. There were strong immune
responses to hsp, particularly Hsp60, in all groups
of animals, both SPF- and conventionally housed
mice. Thus, as shown by others in humans and
mice, immune responses to hsp are a normal phe-
nomenon. Acute EAE was of equivalent severity
and duration in both groups of animals. However,
mice housed in the SPF facility had significantly
more severe relapses than did mice housed in a
conventional facility. In association with this was
a skewing of immune responses to Hsp60 toward
a Thl phenotype. In contrast the strong immune
responses to Hsp60 noted in conventionally house
animals were skewed toward a Th2 phenotype.
Mice injected with CFA intraperitoneally had more
severe disease, and this was seen in both SPF- and
conventionally housed mice. We interpret these
data to indicate that immune responses to hsp, in-
duced by environmental exposure to infectious
agents, play a role in relapses of EAE, and that,
interestingly, fewer infectious exposures are asso-
ciated with more severe disease. Multiple sclerosis
is more common in individuals of higher socioeco-
nomic background, presumably those with fewer
environmental infectious exposures. Our data sug-
gest a mechanism to explain this observation.
Tolerance to Alpha B-Crystallin, a Possible
Autoantigen in Multiple Sclerosis, Alters the
Course of Relapsing Experimental
Autoimmune Encephalomyelitis
Recent data suggest that immune responses to the
small (2SkD) hsp alpha B-crystallin may play a role
in MS. Immune responses to alpha B-crystallin are
found in especially high frequency in persons with
MS,s4 and alpha B-crystallin and Hsp27, another
small hsp, are expressed in regions of acute inflam-
mation in MS brains,ss’s6 We hypothesized that if
immune responses to alpha B-crystallin were im-
portant in a chronic autoimmune CNS disease,
than tolerance to this protein should alter the
course of disease. To study this hypothesis we
studied the role of immune responses to alpha B-
crystallin in mice with relapsing EAE.
Mice were made tolerant to alpha B-crystallin by
injecting them intravenously with high doses of
either alpha B-crystallin or a control protein (BSA
or hen egg lysozyme [HEL]). Animals were then
immunized with PLP139-151 to induce EAE. Mice
made tolerant to alpha B-crystallin had significantly
decreased acute disease and a significantly reduced
frequency and severity of relapses. This was asso-
ciated with a decreased response of CNS lympho-
cytes to the encephalitogenic peptide and a de-
creased expression of inflammatory cytokine mes-
senger RNA (INF-gamma and TNF-alpha) in the
CNS. When mice were made tolerant to alpha B-
crystallin or HEL after the onset of acute EAE,
that is, at the time of at peak disease, there was a
significant decrease in the frequency of relapses of
alpha B-crystallin-tolerant mice, but those mice
that did experience relapses were, as a group,
sicker than HEL-tolerant animals. Immune re-
sponses to PLP139-151 were significantly in-
creased in the CNS of alpha B-crystallin-tolerant
mice compared with controls, but this was not as-
sociated with any changes in patterns of cytokine
secretion. No cross-reactivity could be demonstrated
between alpha B-crystallin and PLP-139-151.
These data are the first to demonstrate that im-
mune responses to a putative autoantigen in MS,
alpha B-crystallin, are also able to alter the course
of relapsing EAE, supporting a role for such re-
sponses in the pathogenesis of chronic, autoim-
mune CNS disease. Understanding the mecha-
nisms behind these phenomena could shed light on
disease processes in MS and may offer insights into
new treatment opportunities.
SUMMARY
Stress or heat shock proteins are constitutively ex-
pressed in normal CNS tissues in a variety of cell
types (oligodendrocytes, astrocytes, and neurons).
Their presence may protect cells from various
stresses, such as hypoxia, anoxia, and excessive ex-
citatory stimulation. Increased amounts of hsp are
expressed in various cells of the CNS during acute
toxic-metabolic states and in chronic degenerative
and inflammatory diseases. Increased expression of
hsp may lead to immune responses to these proteins.
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Antibodies to mycobacterial hsp bind to normal
human myelin and to oligodendrocytes in regions
of MS demyelination. Cellular immune responses
to hsp occur with increased frequency and magni-
tude in persons with MS, especially those with re-
cent onset of disease. In addition, there are popu-
lations ofT cells expressing gamma/delta T cells in
the brains and spinal fluids of persons with MS,
suggesting an in situ immune response to hsps.
Humoral immune responses to hsp are found in
CSF, but no disease specificity has been docu-
mented. Some myelin proteins have sequence ho-
mology with particular hsps. One instance is the
homology between a peptide of mycobacterial
Hsp65 and the myelin protein CNP. Our data on
EAE suggest that immune responses to either
cross-reactive hsp epitopes or whole hsp can
modify the course of both acute and chronic relaps-
ing EAE. In addition, the severity and frequency of
environmental exposure to infectious agents can
modify the course of EAE, possibly by altering the
patterns of immune response to hsp. Finally, toler-
ance to the small hsp, alpha B-crystallin, a putative
autoantigen in persons with MS, alters the course
of relapsing EAE, supporting its role in chronic,
autoimmune CNS disease.
Modifying immune responses to hsp may be a
potential new treatment option for persons with MS.
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